Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
Phase IC Study of Safety and PK of SQ109 300mg Daily
Study Director
Start Date
11 / 2010
Trial Phase
Trial Status
published
Current Enrollment
10
Target Enrollment
10
Overview
Compound Associations
SQ109